It had been reported that in melanoma, metformin suppressed phosphorylation of Smad3 by binding with the TGF-β1 extracellularly and meanwhile reduced the interactions of TβRI and Smad3 intracellularly (Li et al., 2018). Here, SMAD3 is linked to melanoma.